Inventor · disambiguated record
Haruhi Ando
Also filed as: ANDO HARUHI
21 granted patents·67 citations·filing 2012–2022
94Inventor score
Top patents by PatentIndex Score
21 records- 0193US8648079B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2012·Granted Feb 11, 2014·13 cites·3 claims
- 0291US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0391US9440990B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 13, 2016·7 cites·8 claims
- 0491US8871766B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 28, 2014·8 cites·3 claims
- 0591US8865717B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 21, 2014·8 cites·3 claims
- 0690US9193709B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Nov 24, 2015·8 cites·18 claims
- 0787US11174272B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·1 cites·16 claims
- 0886US9586930B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 7, 2017·3 cites·12 claims
- 0985US11560372B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 24, 2023·2 cites·4 claims
- 1081US10550129B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 4, 2020·1 cites·8 claims
- 1181US10273245B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·1 cites·11 claims
- 1279US10144743B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 4, 2018·1 cites·11 claims
- 1378US9598398B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 21, 2017·4 cites·14 claims
- 1475US9296746B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Mar 29, 2016·3 cites·13 claims
- 1575US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 1674US10717748B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 1773US12024505B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jul 2, 2024·0 cites·12 claims
- 1867US9624184B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·1 cites·10 claims
- 1966US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 2061US11970483B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 30, 2024·0 cites·16 claims
- 2160US12162864B2Condensed-cyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →